Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2004
DOI: 10.1016/j.cccn.2003.09.009
|View full text |Cite
|
Sign up to set email alerts
|

Enzyme-linked immunosorbent assay for circulating human resistin: resistin concentrations in normal subjects and patients with type 2 diabetes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

10
86
2
7

Year Published

2006
2006
2021
2021

Publication Types

Select...
7
3

Relationship

1
9

Authors

Journals

citations
Cited by 144 publications
(106 citation statements)
references
References 19 publications
10
86
2
7
Order By: Relevance
“…Nevertheless, the physiological role of resistin on obesity and insulin resistance is unclear, with some studies reporting a significant association between resistin levels, obesity, and insulin resistance (Fujinami et al 2004), whereas others do not (Lee et al 2003). …”
Section: Discussionmentioning
confidence: 99%
“…Nevertheless, the physiological role of resistin on obesity and insulin resistance is unclear, with some studies reporting a significant association between resistin levels, obesity, and insulin resistance (Fujinami et al 2004), whereas others do not (Lee et al 2003). …”
Section: Discussionmentioning
confidence: 99%
“…Monocytes and macrophages are thus thought to be the main source of circulating resistin in humans. Human resistin is also considered to be a biomarker or mediator of metabolic and inflammatory diseases, with increased resistin levels having been associated with metabolic disorders such as obesity, insulin resistance, type 2 diabetes and atherosclerotic cardiovascular disease [4][5][6][7][8]. Recent prospective studies such as the Framingham Offspring Study and Multi-Ethnic Study of Atherosclerosis (MESA) thus found that the circulating resistin level was independently associated with the incidence of atherosclerosis [9,10].…”
Section: Introductionmentioning
confidence: 99%
“…Several theories have also evolved to explain the molecular pathway by which obesity leads to type 2 DM. For example, the medical literature is replete with the evidence-based role of serum resistin levels in this nexus between obesity and type 2 DM [41][42][43][44][45]. Increased obesity has been found to elevate serum resistin levels [41,42], which in turn directly correlate with insulin resistance [43].…”
Section: Obesity and Type 2 Diabetes Mellitus: The Nexusmentioning
confidence: 99%